Advanced search
Publication Cover
Blood Pressure Volume 11, 2002 - Issue 2
Submit an article Journal homepage
38
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Effects of Pergolide on Blood Pressure and Tissue Injury in DOCA-salt Hypertension

Mohammad A. Newaz From the Center for Cardiovascular Diseases, Environmental Toxicology Program, College of Pharmacy and Health Sciences, Texas Southern University, Texas, USA
,
Zivar Yousefipour From the Center for Cardiovascular Diseases, Environmental Toxicology Program, College of Pharmacy and Health Sciences, Texas Southern University, Texas, USA
&
Adebayo Oyekan From the Center for Cardiovascular Diseases, Environmental Toxicology Program, College of Pharmacy and Health Sciences, Texas Southern University, Texas, USA
Pages 110-115 | Published online: 08 Jul 2009

  • Velasco M, Luchsinger A. Dopamine: pharmacologie and therapeutic aspects. Am J Ther 1998; 5: 37-43.
  • Cavero I, Lefevre-Borg F, Lhoste F, Sabatier C, Richer C, Giudicelli JF. Pharmacological, hemodynamic and autonomie nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. J Pharmacol Exp Ther 1984; 228: 779-91.
  • Lahlou S. Cardiovascular responses to intrathecal dopamine receptor agonists in conscious DOCA-salt hypertensive rats. Fundam Clin Pharmacol 1999; 13: 624-34.
  • Barren RJ, Lokhandwala MF. Central and peripheral dopaminergic mechanisms in the cardiovascular actions of pergolide in neurogenic hypertensive dogs. Eur J Pharmacol 1983;96:211-26.
  • Cavero I, Massingham R, Lefevere-Borg F. Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part II: Sites and mechanisms of action of dopamine receptor agonists. Life Sci 1982; 31: 1059-69.
  • Gassen M, Gross A, Youdim MB. Apomorphine enantiomers protect cultured pheochromocytoma (PC 12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine. Mov Disord 1998; 13: 242-8.
  • Gomez-Vargas M, Nishibayashi-Asanuma S, Asanuma M, Kondo Y, Iwata E, Ogawa N. Pergolide scavenges both hydroxyl ans nitric oxide free radicals in vitro and inhibits lipid peroxidation in different regions of the rat brain. Brain Res 1998; 790: 202-8.
  • Nicod L, Rodriguez S, Letang JM. Antioxidant status, lipid peroxidation, mixed function oxidase and UDP-glucuronyl transferase activities in livers from control and DOCA-salt hypertensive male Sprague Dawley rats. Mol Cell Biochem 2000; 203: 33-9.
  • Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administraion attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 2001; 37(2 Part 2): 781-6.
  • Nicod L, Rodriguez S, Letang JM. Cloflbric acid or diethylmameate supplemented diet decrease blood pressure in DOCA-salt treated male Sprague Dawley rats -- relation with liver antioxidant status. Mol Cell Biochem 2000; 213: 65-73.
  • Oyekan AO, McAward K, Conetta J, Rosenfeld L, McGiff JC. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension. Am J Physiol 1999; 276: R766-775.
  • Lariviere R, Day R, Schiffrin EL. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-sat hypertensive rats. Hypertension 1993; 21(6 Pt 2): 916-21.
  • Kahler J, Ewert A, Weckmuller J. Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol 2001; 38: 49-57.
  • Yura T, Fukunaga M, Khan R, Nassar GN, Badr KF, Montera A. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int 1999; 56: 471-8.
  • Newaz MA, Adeeb NNN. Detection of xanthine oxidase in human plasma. Med J Malaysia 1998; 53: 70-5.
  • Kinsolving CR, Wat kins BF, Borrelli AR, Kaiser FC. Wu FS. Flavodilol: a new antihypertensive agent. J Cardiovasc Pharmacol 1989; 14: 127-41.
  • Cavero I, Lorrain J, Di Paola ED, et al. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypotensive rats. J Pharmacol Exp Ther 1985: 235: 798-809.
  • Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 2001; 218: 97-103.
  • Fink GD, Johnson RJ, Galligan JJ. Mechanism of increased venous smooth muscle tone in deoxycorticosterone acetatesalt hypertension. Hypertension 2000; 35(1 Pt 2): 464-9.
  • Yu M, Gopalakrishnan V, McNeill R. Role of endothelin and vasopressin in DOCA-salt hypertension. Br J Pharmacol 2001; 132: 1447-54.
  • Schiffrin EL. Endothelin: role in experimental hypertension. J Cardiovasc Pharmacol 2000; 35(4 Suppl 2): S33-5.
  • Schiffrin EL, Lariviere R, Li JS, Sventek P. Enhanced expression of endothelin-1 gene in blood vessels of DOCAsalt hypertensive rats: correlation with vascular hypertrophy. J Vase Res 1996; 33: 235-48.
  • Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy. J Cardiovasc Pharmacol 1995; 26 Suppl 3: S5-8.
  • Leander JD 1987. Effects of specific Dl and D2 dopamine agonists and pergolide on urinary outputs of rats. Arch Intl Pharmacodyn Ther 1987; 289: 290-5.
  • Chibalin AV, Ogimoto G, Pedemonte CH. Dopamineinduced endocytosis of Na+-K+-ATPaSe is initiated by phosphorylation of Ser-18 in the rat subunit and is responsible for the decreased activity in epithelial cells. J Bio Chem 1999; 274: 1920-7.
  • Nathanson JA, Scavone C, Scanion C, McKee M. The cellular Na pump as a site of action for carbon monoxide and glutamate: a mechanism for long term modulation of cellular injury. Neuron 1995; 14: 781-94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.